Home › Research › Mild cognitive impairment
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
McCleery J, Abraham RP, Denton DA, Rutjes AW, Chong LY, Al-Assaf AS, Griffith DJ, Rafeeq S et al.. The Cochrane database of systematic reviews, 2018-11-01
Topic: Risk, prevention and care in population studies
It has been suggested that various different vitamin and mineral supplements might be useful in maintaining cognitive function and delaying the onset of dementia. Data collection and analysis We sought data on our primary outcomes of dementia incidence and overall cognitive function and on secondary outcomes of episodic memory, executive function, speed of processing, quality of life, functional performance, clinical global impression, adverse events, and mortality. We used GRADE methods to assess the overall quality of evidence for each comparison and outcome. Main results We included five trials with 879 participants which investigated B vitamin supplements. Our primary efficacy outcomes were the incidence of dementia and scores on measures of overall cognitive function. None of the trials reported the incidence of dementia and the evidence on overall cognitive function was of very low-quality. The available data did not allow us to conduct analyses, but the authors reported no significant effect of three years of supplementation with vitamin E on overall cognitive function, episodic memory, speed of processing, clinical global impression, functional performance, adverse events, or mortality (five deaths in each group).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
McCleery, J., Abraham, R. P., Denton, D. A., Rutjes, A. W., Chong, L. Y., Al-Assaf, A. S., et al. (2018). Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd011905.pub2
Vancouver
McCleery J, Abraham RP, Denton DA, Rutjes AW, Chong LY, Al-Assaf AS, et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. The Cochrane database of systematic reviews. 2018. doi:10.1002/14651858.cd011905.pub2. PMID: 30383288.
BibTeX
@article{mccleery2018-30383288,
author = {McCleery, J. and Abraham, R. P. and Denton, D. A. and Rutjes, A. W. and Chong, L. Y. and Al-Assaf, A. S. and Griffith, D. J. and Rafeeq, S. and others},
title = {{Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment}},
journal = {The Cochrane database of systematic reviews},
year = {2018},
doi = {10.1002/14651858.cd011905.pub2},
pmid = {30383288},
url = {https://doi.org/10.1002/14651858.cd011905.pub2}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- It has been suggested that various different vitamin and mineral supplements might be useful in maintaining cognitive function and delaying the onset of dementia.
- Data collection and analysis We sought data on our primary outcomes of dementia incidence and overall cognitive function and on secondary outcomes of episodic memory, executive function, speed of processing, quality of life, functional performance, clinical global impression, adverse events, and mortality.
- We used GRADE methods to assess the overall quality of evidence for each comparison and outcome.
- Main results We included five trials with 879 participants which investigated B vitamin supplements.
- Our primary efficacy outcomes were the incidence of dementia and scores on measures of overall cognitive function.
Why it matters
This review of five trials with 879 participants found no significant effect of three years of vitamin E supplementation on overall cognitive function or other outcomes, and none of the trials reported dementia incidence. The evidence on overall cognitive function was of very low quality.
Study details
- Study designsystematic review
- Participants516
- Effect sizeHR 1.02
- Evidence strengthHigh
How this study scored 73/100
Published in a leading specialty journal, and it is a systematic review of all the studies on the question.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (The Cochrane database of systematic reviews) |
| Journal's citation record | 3 / 4 | Cochrane Database of Systematic Reviews: journal h-index 468 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 2 / 4 | 516 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 5 / 7 | Cited 160 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 16.0 citations a year over 10 year(s) since 2018 |
| Impact for its field and year | 4 / 6 | Cited 11.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 2 / 4 | Cited 34 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Naji Tabet: h-index 37 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Bern: institution h-index 977 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 16 institution(s) in 6 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30383288) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 73 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/14651858.cd011905.pub2
- PubMed: 30383288
- Original source →
- Free full text: Cochrane Database of Systematic Reviews →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 28.
Later studies that cite this one
5 studies in the alzhub library list this one in their references. Showing the 4 highest-scoring.
Related studies in Mild cognitive impairment
Also tagged “controlled”
1,116 studies in the library carry the topic tag “controlled”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,116 tagged studies.